Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Chromosome 17 deletion × Alemtuzumab × 1 year × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Transplantation 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Adenocarcinoma, Clear Cell 1

Interventions

pomalidomide 2 fludarabine phosphate 2 Dexamethasone 2 venetoclax 1 pembrolizumab 1 ibrutinib 1 fludarabine 1 daratumumab 1 acalabrutinib 1 Tacrolimus 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Melphalan 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡